SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 607 filers reported holding SEAGEN INC in Q3 2023. The put-call ratio across all filers is 3.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,897 | +12.3% | 37,222 | +1.9% | 0.05% | +10.6% |
| Q2 2023 | $7,032 | +6.6% | 36,538 | +12.1% | 0.05% | +6.8% |
| Q1 2023 | $6,597 | +239.0% | 32,582 | +115.2% | 0.04% | +214.3% |
| Q4 2022 | $1,946 | -99.9% | 15,143 | -23.3% | 0.01% | -30.0% |
| Q3 2022 | $2,701,000 | -27.7% | 19,741 | -6.5% | 0.02% | -20.0% |
| Q2 2022 | $3,735,000 | -7.4% | 21,108 | -24.6% | 0.02% | +19.0% |
| Q1 2022 | $4,034,000 | -0.9% | 28,007 | +6.3% | 0.02% | +16.7% |
| Q4 2021 | $4,072,000 | -72.5% | 26,341 | -69.7% | 0.02% | -77.5% |
| Q3 2021 | $14,781,000 | +47.1% | 87,047 | +36.8% | 0.08% | +45.5% |
| Q2 2021 | $10,048,000 | +53.5% | 63,644 | +35.0% | 0.06% | +52.8% |
| Q1 2021 | $6,547,000 | -49.3% | 47,147 | -36.1% | 0.04% | -53.8% |
| Q4 2020 | $12,925,000 | – | 73,796 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |